Zomedica Stock Future Predictions

Thousands of words have undoubtedly been written regarding retail enthusiasm for gamestop, amc, blackberry, and others, but an. (amex:zom) at last check was buoying at $0.52 on friday, november 12 with a rise of 0.31% from its closing price on previous day.

Zomedica Corp Price Zom Forecast With Price Charts

Zomedica was a popular penny stock in the early part of 2021.

Zomedica stock future predictions. Zomedica stock price predictions for april 2022. However, solely looking at the historical price movement is usually. 26 rows zomedica stock forecast for tomorrow, week, month.

Zomedica pharmaceuticals stock price prediction is an act of determining the future value of zomedica pharmaceuticals shares using few different conventional methods such as eps estimation, analyst consensus, or fundamental intrinsic valuation. Zomedica stock forecast is based on your current time horizon. Marketbeat users like zomedica stock more than the stock of other basic materials companies.

This is a technical indicator used by some traders and investors who view these figures as an important factor in the analysis of a stock’s current value and as a predictor of its future price movement. Is $.38 , for 2022 dec. During the day the stock fluctuated 5.42% from a day low at $0.37 to a day high of $0.38.

(zom) stock forecast and price target. This page was last updated on 11/28/2021 by marketbeat.com staff. Is $.38 , for 2026 dec.

Averaged zomedica stock price for month 0.2227. However, based on the sales forecast for 2021, zom stock is extremely overvalued —. Of course, that’s exceptionally bullish for zom stock.

In this article, we’ll discuss our zom stock forecast in detail. The small number of analysts offering a zom stock prediction remain pessimistic about the stock’s outlook, despite reductions to r&d costs and the promise of future revenue streams. Today 200 day moving average is the resistance level (0.917 $).

We’ll touch on what zomedica is and the stock’s outlook before highlighting where you can buy zom stocks today. 50 day moving average is. Maximum value 0.2381, while minimum 0.2111.

Series d warrants security type: The p/e ratio of zomedica pharmaceuticals corp. The zomedica pharmaceuticals corp stock price gained 1.33% on the last trading day (thursday, 2nd dec 2021), rising from $0.38 to $0.38.

Zomedica stock future price prediction. Is $.56 , for 2025 dec. We will be moving onto the number of outstanding shares.

But shares have plunged more than 80% below the high set in the first quarter. Zomedica stock forecasts are adjusted once a day based on the closing price of the previous trading day. This is a technical indicator used by some traders and investors who view these figures as an important factor in the analysis of a stock’s current value and as a predictor of its future price movement.

The zomedica stock prediction results are shown below and presented as a graph, table and text information. Zoetis stock price is near $160. The forecast for beginning of april 0.2170.

The minimum target price for zomedica analysts is $ 1.2. Is $.27 , and for 2031 dec. Pathway to $3 for zomedica stock

Analyst projections state that zom is forecast to be at a low of $1.20 and a high of $1.20. Zomedica's (nyse:zom) stock has been on fire over the past month. Price at the end 0.2246, change for april 3.50%.

However, the stock is on a move again. In the past three months, zomedica pharmaceuticals corp. Nokia stock forecast 2021, 2022, 2023.

Is $.32 , for 2030 dec. The p/e ratio of zomedica pharmaceuticals corp. Taking a look at stock we notice that its last check on previous day was $0.51 and 5y monthly beta was reading 0.40 with its price kept floating in the range of $0.51 and $0.53 on the day.

Hc wainwright appears to be one of the few investment banks offering coverage. The successful prediction of zomedica pharmaceuticals' future. Idexx is trading well over $500 a piece.

Bottom line zomedica is a company that has lost its luster, at least in terms of being considered a meme stock. Any sort of positive momentum the company had earlier this year appears to have waned. 70.00% of marketbeat users gave zomedica an outperform vote while basic materials companies recieve an average of 62.98% outperform votes by marketbeat users.

(zom.v) insiders have not sold or bought any company stock.